Alcohol protracted withdrawal syndrome: The role of anhedonia

被引:74
|
作者
Martinotti, G. [1 ]
Di Nicola, M. [1 ]
Reina, D. [1 ]
Andreoli, S. [1 ]
Foca, F. [1 ]
Cunniff, A. [2 ]
Tonioni, F. [1 ]
Bria, P. [1 ]
Janiri, L. [1 ]
机构
[1] Catholic Univ Med Sch, Dept Psychiat Addict Behav, Rome, Italy
[2] Smoking Cessat Dept, Natl Hlth Serv Lothian, Edinburgh, Midlothian, Scotland
关键词
protracted withdrawal; alcohol; anhedonia; craving; abstinence; relapse;
D O I
10.1080/10826080701202429
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims: The aim of the present study is to characterize the relevance of withdrawal symptoms during the first 12 months of abstinence and their relation to anhedonia and craving. Methods: 102 detoxified subjects meeting clinical criteria for Alcohol Dependence in Remission were recruited at various time since the detoxification and subdivided into four groups according to the length of abstinence (group 1: 15-30 days; group 2: 30-90 days; group 3: 90-180 days; group 4: 180-360). Withdrawal symptomatology was assessed through the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar). The Visual Analogue Scale (VAS) for craving, the Snaith-Hamilton Pleasure Scale (SHAPS) and the Subscale for Anhedonia in the Scale for the Assessment of Negative Symptoms (SANSanh) where the other instruments employed. Results: Both anhedonia and withdrawal symptoms were identified in all the groups considered. SHAPS score and VAS for craving showed a significant difference between group 1 and groups 2, 3, and 4. As to CIWA-Ar items, apart from "orientation/clouding of sensorium" that was higher in groups 3 and 4 with respect to both groups 1 and 2, withdrawal symptoms were not significantly different between the periods considered. SHAPS and SANSanh were positively correlated to CIWA-Ar total score, "nausea and vomiting," and "headache/fullness in head." Discussion: The results of this study suggest the relevance of protracted withdrawal well beyond the limited period following the abrupt cessation of alcohol intake. The clinical dimension of anhedonia cannot be separated from the other behavioral symptoms of withdrawal and should be considered as part of the same process.
引用
收藏
页码:271 / 284
页数:14
相关论文
共 50 条
  • [21] Clinical efficacy treated with L-tetrahydropalmatine on protracted withdrawal syndrome in heroin addicts
    Yang, Zheng
    Li, Shijiang
    Chen, Hong-xian
    Hao, Wei
    Jin, Guo-Zhang
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 425 - 425
  • [22] The hollow-face illusion in alcohol withdrawal syndrome
    Bachetti, Livia da Silva
    Cesari Quaglia, Maria Amelia
    Alves, Arthur
    de Oliveira, Marcos Santos
    ARQUIVOS BRASILEROS DE PSICOLOGIA, 2013, 65 (03): : 436 - 451
  • [23] Role of GABAB receptor in alcohol dependence:: Reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics
    Colombo, G
    Addolorato, G
    Agabio, R
    Carai, MAM
    Pibiri, F
    Serra, S
    Vacca, G
    Gessa, GL
    NEUROTOXICITY RESEARCH, 2004, 6 (05) : 403 - 414
  • [24] Gamma-hydroxybutyric acid in the treatment of alcohol withdrawal syndrome in patients admitted to hospital
    Korninger, C
    Roller, RE
    Lesch, OM
    ACTA MEDICA AUSTRIACA, 2003, 30 (03) : 83 - 86
  • [25] Role of GABAB receptor in alcohol dependence: Reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics
    Giancarlo Colombo
    Giovanni Addolorato
    Roberta Agabio
    Mauro A. M. Carai
    Fabio Pibiri
    Salvatore Serra
    Giovanni Vacca
    Gian Luigi Gessa
    Neurotoxicity Research, 2004, 6 : 403 - 414
  • [26] Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients
    Dixit, Deepali
    Endicott, Jeffrey
    Burry, Lisa
    Ramos, Liz
    Yeung, Siu Yan Amy
    Devabhakthuni, Sandeep
    Chan, Claire
    Tobia, Anthony
    Bulloch, Marilyn N.
    PHARMACOTHERAPY, 2016, 36 (07): : 797 - 822
  • [27] Liver disease in heavy drinkers with and without alcohol withdrawal syndrome
    Barrio, E
    Tomé, S
    Rodríguez, I
    Gude, F
    Sánchez-Leira, J
    Pérez-Becerra, E
    González-Quintela, A
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (01): : 131 - 136
  • [28] Adjunctive Phenobarbital for Alcohol Withdrawal Syndrome: A Focused Literature Review
    Murphy, Julie A.
    Curran, Brittany M.
    Gibbons, William A., III
    Harnica, Holly M.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (12) : 1515 - 1524
  • [29] QUANTIFICATION OF THE ALCOHOL-WITHDRAWAL SYNDROME IN 487 ALCOHOLIC PATIENTS
    BENZER, DG
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 1990, 7 (02) : 117 - 123
  • [30] The effect of alcohol withdrawal syndrome severity on sleep, brain and cognition
    Laniepce, Alice
    Cabe, Nicolas
    Andre, Claire
    Bertran, Francoise
    Boudehent, Celine
    Lahbairi, Najlaa
    Maillard, Angeline
    Mary, Alison
    Segobin, Shailendra
    Vabret, Francois
    Rauchs, Geraldine
    Pitel, Anne-Lise
    BRAIN COMMUNICATIONS, 2020, 2 (02)